JP2022553017A5 - - Google Patents
Info
- Publication number
- JP2022553017A5 JP2022553017A5 JP2022523126A JP2022523126A JP2022553017A5 JP 2022553017 A5 JP2022553017 A5 JP 2022553017A5 JP 2022523126 A JP2022523126 A JP 2022523126A JP 2022523126 A JP2022523126 A JP 2022523126A JP 2022553017 A5 JP2022553017 A5 JP 2022553017A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- subject
- probiotic preparation
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025116425A JP2025163045A (ja) | 2019-10-18 | 2025-07-10 | 腸内微生物叢によりｓｃｆａ産生を促進する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201915144A GB201915144D0 (en) | 2019-10-18 | 2019-10-18 | Method of promoting SCFA production by gut microbiota |
| GB1915144.8 | 2019-10-18 | ||
| PCT/GB2020/052621 WO2021074649A2 (en) | 2019-10-18 | 2020-10-16 | Methods of promoting scfa production by gut microbiota |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025116425A Division JP2025163045A (ja) | 2019-10-18 | 2025-07-10 | 腸内微生物叢によりｓｃｆａ産生を促進する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553017A JP2022553017A (ja) | 2022-12-21 |
| JP2022553017A5 true JP2022553017A5 (https=) | 2023-10-20 |
| JP7809339B2 JP7809339B2 (ja) | 2026-02-02 |
Family
ID=68728134
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523126A Active JP7809339B2 (ja) | 2019-10-18 | 2020-10-16 | 腸内微生物叢によりｓｃｆａ産生を促進する方法 |
| JP2025116425A Withdrawn JP2025163045A (ja) | 2019-10-18 | 2025-07-10 | 腸内微生物叢によりｓｃｆａ産生を促進する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025116425A Withdrawn JP2025163045A (ja) | 2019-10-18 | 2025-07-10 | 腸内微生物叢によりｓｃｆａ産生を促進する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12419921B2 (https=) |
| EP (1) | EP4044830A2 (https=) |
| JP (2) | JP7809339B2 (https=) |
| CN (2) | CN114745970B (https=) |
| AU (1) | AU2020368684B2 (https=) |
| BR (1) | BR112022007413A2 (https=) |
| CA (1) | CA3154083A1 (https=) |
| DE (1) | DE20796905T1 (https=) |
| ES (1) | ES2922359T1 (https=) |
| GB (1) | GB201915144D0 (https=) |
| MX (1) | MX2022004382A (https=) |
| WO (1) | WO2021074649A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
| CN113875975B (zh) * | 2021-09-03 | 2023-06-30 | 许昌学院 | 一种利用小麦加工副产物制备后生元的发酵工艺 |
| WO2024216281A1 (en) * | 2023-04-14 | 2024-10-17 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for treatment of circadian rhythm disorders |
| WO2025217259A1 (en) * | 2024-04-10 | 2025-10-16 | Postbiotics Plus Research Llc | Use of postbiotics for treating or preventing disruptions of the gut-brain axis |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6899872B1 (en) * | 1995-11-27 | 2005-05-31 | Standa Lab Sa | Absorbable dietary composition for improving the biological balance of intestinal tract flora |
| GB2418431A (en) * | 2004-09-27 | 2006-03-29 | Multigerm Uk Entpr Ltd | Metabolically active micro organisms and methods for their production |
| WO2011060123A1 (en) * | 2009-11-12 | 2011-05-19 | Nestec S.A. | Nutritional composition for promoting gut microbiota balance and health |
| US8591412B2 (en) * | 2009-11-18 | 2013-11-26 | Nohands, Llc | Method and system for preventing virus-related obesity and obesity related diseases |
| US9707207B2 (en) * | 2010-05-26 | 2017-07-18 | The United States Of America As Represented By The Department Of Veterans Affairs | Method for diagnosing, preventing, and treating neurological diseases |
| US10086018B2 (en) * | 2011-02-04 | 2018-10-02 | Joseph E. Kovarik | Method and system for reducing the likelihood of colorectal cancer in a human being |
| US10512661B2 (en) | 2011-02-04 | 2019-12-24 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease |
| US10548761B2 (en) * | 2011-02-04 | 2020-02-04 | Joseph E. Kovarik | Method and system for reducing the likelihood of colorectal cancer in a human being |
| US10842834B2 (en) | 2016-01-06 | 2020-11-24 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease |
| DK3329927T3 (da) * | 2011-11-16 | 2023-12-11 | Multigerm Uk Entpr Ltd | IBS-behandling med probiotika |
| GB201219873D0 (en) * | 2012-11-05 | 2012-12-19 | Multigerm Uk Entpr Ltd | Diverticulitis treatment |
| US8889633B2 (en) * | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| WO2015159125A1 (en) * | 2014-04-15 | 2015-10-22 | Compagnie Gervais Danone | Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after antibiotic dysbiosis |
| EP3639834B1 (en) * | 2016-02-04 | 2023-07-12 | Universiteit Gent | Use of microbial communities for human and animal health |
| US10055534B2 (en) * | 2016-03-17 | 2018-08-21 | Applied Materials Israel Ltd. | System and method for design based inspection |
| PL3443071T3 (pl) * | 2016-04-11 | 2022-03-28 | Wageningen Universiteit | Nowe gatunki bakterii |
| US20180357375A1 (en) | 2017-04-04 | 2018-12-13 | Whole Biome Inc. | Methods and compositions for determining metabolic maps |
| US11730749B2 (en) | 2017-05-05 | 2023-08-22 | Plexus Worldwide, Llc | Compositions and methods for improving gut health |
| AU2018313765A1 (en) | 2017-08-07 | 2020-02-27 | Finch Therapeutics, Inc. | Compositions and methods for decolonizing antibotic-resistant bacteria in the gut |
| AU2019216129B2 (en) * | 2018-02-02 | 2022-03-17 | Kobiolabs, Inc. | Lactobacillus plantarum KBL396 strain and use thereof |
| GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
| FR3136482A1 (fr) * | 2021-08-01 | 2023-12-15 | Snipr Biome Aps | Ingenierie du microbiote |
-
2019
- 2019-10-18 GB GB201915144A patent/GB201915144D0/en not_active Ceased
-
2020
- 2020-10-16 US US17/769,125 patent/US12419921B2/en active Active
- 2020-10-16 BR BR112022007413A patent/BR112022007413A2/pt unknown
- 2020-10-16 CN CN202080081506.3A patent/CN114745970B/zh active Active
- 2020-10-16 ES ES20796905T patent/ES2922359T1/es active Pending
- 2020-10-16 CN CN202410747338.7A patent/CN118593548A/zh active Pending
- 2020-10-16 AU AU2020368684A patent/AU2020368684B2/en active Active
- 2020-10-16 MX MX2022004382A patent/MX2022004382A/es unknown
- 2020-10-16 CA CA3154083A patent/CA3154083A1/en active Pending
- 2020-10-16 EP EP20796905.6A patent/EP4044830A2/en active Pending
- 2020-10-16 JP JP2022523126A patent/JP7809339B2/ja active Active
- 2020-10-16 WO PCT/GB2020/052621 patent/WO2021074649A2/en not_active Ceased
- 2020-10-16 DE DE20796905.6T patent/DE20796905T1/de active Pending
-
2025
- 2025-07-10 JP JP2025116425A patent/JP2025163045A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022553017A5 (https=) | ||
| Vasquez et al. | Probiotics as beneficial dietary supplements to prevent and treat cardiovascular diseases: uncovering their impact on oxidative stress | |
| Roselli et al. | Use of synbiotics for ulcerative colitis treatment | |
| Liu et al. | The contribution of the gut-liver axis to the immune signaling pathway of NAFLD | |
| CN108289918A (zh) | 经巴氏灭菌的艾克曼菌用于治疗代谢病症的用途 | |
| CN110167637A (zh) | 3-羟基丁酸甘油酯用于偏头痛症状管理 | |
| BR112012008005B1 (pt) | composição compreendendo cepas de lactobacillus plantarum | |
| Hung et al. | Lactobacillus paracasei subsp. paracasei NTU 101 ameliorates impaired glucose tolerance induced by a high-fat, high-fructose diet in Sprague-Dawley rats | |
| US9314444B2 (en) | Composition and method for treatment of NASH | |
| CN117398392A (zh) | 一种调节肠道微生物群的治疗方法 | |
| WO2016116580A1 (en) | Nutritional composition useful in the treatment of ibd patients | |
| CN103702668A (zh) | 治疗糖尿病的组合物和方法 | |
| JP6986445B2 (ja) | １５−ｈｅｐｅを含む組成物、およびそれを用いて線維症を処置または防止する方法 | |
| Lu et al. | Bacillus licheniformis Zhengchangsheng® inhibits obesity by regulating the AMP-activated protein kinase signaling pathway | |
| ES2922359T1 (es) | Métodos para promover la producción de SCFA por la microbiota intestinal | |
| Obayomi et al. | Role of enteric dysbiosis in the development of central obesity: a review | |
| ES2545105T3 (es) | Composición farmacéutica a base de un agente protector hepático y de un agente prebiótico, su preparación y uso | |
| Lu et al. | Short-chain fatty acids alleviate cholestatic liver injury by improving gut microbiota and bile acid metabolism | |
| Radchenko et al. | Nonalcoholic steatohepatitis and biliary sludge in people with metabolic syndrome | |
| Narayanan et al. | Role of gut microbiota in human health and diseases | |
| Mosca et al. | Metabolic associated fatty liver disease in children and adolescents: mechanisms of a silent epidemic and therapeutic options | |
| US10456436B2 (en) | Use of herbal saponins to regulate gut microflora | |
| Castelnuovo et al. | Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease | |
| Chibbar et al. | Treatment of inflammatory bowel disease in ulcerative colitis | |
| CN116251096A (zh) | Iaa和/或ila在制备治疗肥胖、局部脂肪堆积及其合并症的药物、食品或护肤品中的用途 |